Literature DB >> 9568082

Clinicopathologic differences between gastric remnant cancer and primary cancer in the upper third of the stomach.

T Imada1, Y Rino, M Takahashi, M Shiozawa, S Hatori, Y Noguchi, T Amano, O Kobayashi, M Sairenji, H Motohashi.   

Abstract

BACKGROUND: The prognosis of gastric remnant cancer is considered to be poor compared with that of primary cancer.
MATERIALS AND METHODS: This study was conducted to elucidate the differences of clinicopathologic findings and treatment results between 59 patients with gastric remnant cancer (GRC) and 579 patients with primary proximal gastric cancer (PGC).
RESULTS: There was no significant difference in the incidence of lymph node metastasis between GRC and PGC. However, changes in the metastatic pattern to lymph nodes were observed in GRC. In GRC, the tumor easily invaded the neighboring organs due to the adhesions around the remnant stomach, resulting in a low resectability with curative intent. The 5-year survival rate after curative resection for advanced GRC was 50.9%. GRC patients without serosal invasion had a good prognosis.
CONCLUSION: Although the survival rate after curative resection for GRC patients was similar to that of PGC, GRC patients without serosal invasion had a better prognosis. Therefore, early detection is an important way to improve overall survival in GRC.

Entities:  

Mesh:

Year:  1998        PMID: 9568082

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy.

Authors:  Jong Yeul Lee; Il Ju Choi; Soo-Jeong Cho; Chan Gyoo Kim; Myeong-Cherl Kook; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim
Journal:  Surg Endosc       Date:  2009-12-09       Impact factor: 4.584

2.  Clinicopathological characteristics and survival difference between gastric stump carcinoma and primary upper third gastric cancer.

Authors:  Masanori Tokunaga; Takeshi Sano; Shigekazu Ohyama; Naoki Hiki; Tetsu Fukunaga; Kazuhiko Yamada; Toshiharu Yamaguchi
Journal:  J Gastrointest Surg       Date:  2012-12-12       Impact factor: 3.452

3.  The pattern of lymph node metastasis and the suitability of 7th UICC N stage in predicting prognosis of remnant gastric cancer.

Authors:  Fangxuan Li; Rupeng Zhang; Han Liang; Hui Liu; Jichuan Quan; Jingzhu Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-03       Impact factor: 4.553

4.  Twenty-two metachronous multiple signet-ring cell carcinomas treated with repeated gastrectomies and repeated endoscopic mucosal resections: report of a case.

Authors:  Masanori Tokunaga; Shigekazu Ohyama; Kensuke Kuraoka; Naoki Hiki; Tetsu Fukunaga; Tomohiro Tsuchida; Junko Fujisaki; Noriko Yamamoto; Toshiharu Yamaguchi
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

5.  [Gastric stump carcinoma: frequency, treatment, complications and prognosis].

Authors:  H Nienhüser; S Blank; L Sisic; R Kunzmann; U Heger; K Ott; M W Büchler; T Schmidt; A Ulrich
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

6.  Gastric remnant cancer: an old problem with novel concerns.

Authors:  Ozgur Firat; Adem Guler; Murat Sozbilen; Sinan Ersin; Hasan Kaplan
Journal:  Langenbecks Arch Surg       Date:  2008-07-08       Impact factor: 3.445

Review 7.  Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Takeo Fukagawa; Yoshio Haga; Koji Oba
Journal:  Gastric Cancer       Date:  2015-12-14       Impact factor: 7.370

8.  Survival and surgical outcomes of cardiac cancer of the remnant stomach in comparison with primary cardiac cancer.

Authors:  Yi Wang; Chang-Ming Huang; Jia-Bin Wang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jian-Xian Lin; Jun Lu
Journal:  World J Surg Oncol       Date:  2014-01-27       Impact factor: 2.754

9.  Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi-institutional study.

Authors:  Qi-Yue Chen; Qing Zhong; Jun-Feng Zhou; Xian-Tu Qiu; Xue-Yi Dang; Li-Sheng Cai; Guo-Qiang Su; Dong-Bo Xu; Guang-Tan Lin; Kai-Qing Guo; Zhi-Yu Liu; Qiu-Xian Chen; Ping Li; Teng-Wen Li; Jian-Wei Xie; Shuang-Ming Lin; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Chao-Hui Zheng; Wei Lin; Qing-Liang He; Chang-Ming Huang
Journal:  Cancer Sci       Date:  2019-12-26       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.